FDA is providing an update on adverse events reported to the Agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma, and systemic signs and symptoms referred to by patients as breast implant illness, which some patients report after receiving breast implants.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
